Tempest Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tempest Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
  • Tempest Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$10.6M, a 55.6% decline year-over-year.
  • Tempest Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$35.5M, a 14.2% decline year-over-year.
  • Tempest Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$29.5M, a 17.4% increase from 2022.
  • Tempest Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$35.7M, a 26.2% decline from 2021.
  • Tempest Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$28.3M, a 47.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$29.5M +$6.22M +17.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 -$35.7M -$7.41M -26.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$28.3M -$9.09M -47.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$19.2M +$25.4M +56.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 -$44.6M -$17.4M -63.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 -$27.2M +$57.4M +67.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 -$84.6M -$2.32M -2.82% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$82.3M -$9.04M -12.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 -$73.2M -$23.7M -47.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 -$49.5M -$20.5M -70.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 -$29M -$15.5M -115% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 -$13.5M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.